Insider Transactions in Q1 2024 at Vericel Corp (VCEL)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
3,278
-12.29%
|
$167,178
$51.57 P/Share
|
|
Mar 27
2024
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,278
+10.94%
|
$9,834
$3.74 P/Share
|
|
Mar 14
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-8.24%
|
$770,000
$44.02 P/Share
|
|
Mar 14
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+7.61%
|
$52,500
$3.02 P/Share
|
|
Mar 13
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-8.24%
|
$770,000
$44.67 P/Share
|
|
Mar 13
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+7.61%
|
$52,500
$3.02 P/Share
|
|
Mar 11
2024
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,874
-89.24%
|
$346,456
$44.71 P/Share
|
|
Mar 08
2024
|
Sean C. Flynn Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,115
-97.98%
|
$365,175
$45.33 P/Share
|
|
Mar 07
2024
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,634
-53.86%
|
$73,530
$45.0 P/Share
|
|
Feb 20
2024
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,106
-1.79%
|
$152,194
$49.5 P/Share
|
|
Feb 20
2024
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,075
+3.92%
|
-
|
|
Feb 20
2024
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,286
-16.96%
|
$63,014
$49.5 P/Share
|
|
Feb 20
2024
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,920
+25.33%
|
-
|
|
Feb 20
2024
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,268
-5.89%
|
$111,132
$49.5 P/Share
|
|
Feb 20
2024
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,380
+15.9%
|
-
|
|
Feb 20
2024
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,025
-3.09%
|
$883,225
$49.5 P/Share
|
|
Feb 20
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
38,887
+6.2%
|
-
|
|
Feb 20
2024
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,250
-13.42%
|
$159,250
$49.5 P/Share
|
|
Feb 20
2024
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,075
+22.23%
|
-
|
|
Feb 20
2024
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,731
-21.86%
|
$280,819
$49.5 P/Share
|
|
Feb 20
2024
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,887
+30.34%
|
-
|
|
Feb 20
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
722
-2.99%
|
$36,100
$50.01 P/Share
|
|
Feb 20
2024
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
722
+2.91%
|
$2,166
$3.74 P/Share
|
|
Feb 15
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-9.14%
|
$840,000
$48.85 P/Share
|
|
Feb 15
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+8.37%
|
$52,500
$3.02 P/Share
|
|
Feb 14
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
17,500
-9.14%
|
$805,000
$46.99 P/Share
|
|
Feb 14
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+8.37%
|
$52,500
$3.02 P/Share
|
|
Feb 12
2024
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,477
-1.96%
|
$163,419
$47.42 P/Share
|
|
Feb 12
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.05%
|
-
|
|
Feb 12
2024
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,782
-40.05%
|
$83,754
$47.42 P/Share
|
|
Feb 12
2024
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+44.03%
|
-
|
|
Feb 12
2024
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
775
-1.42%
|
$36,425
$47.42 P/Share
|
|
Feb 12
2024
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,625
+2.88%
|
-
|
|
Jan 29
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
2,300
-8.95%
|
$101,200
$44.22 P/Share
|
|
Jan 25
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
200
-0.77%
|
$8,800
$44.02 P/Share
|
|
Jan 22
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
8,000
-9.09%
|
$328,000
$41.83 P/Share
|
|
Jan 22
2024
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+9.41%
|
$12,000
$4.12 P/Share
|
|
Jan 18
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
16,726
-8.96%
|
$635,588
$38.58 P/Share
|
|
Jan 18
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,726
+8.22%
|
$50,178
$3.02 P/Share
|
|
Jan 17
2024
|
Dominick Colangelo President and CEO |
SELL
Open market or private sale
|
Direct |
16,726
-8.96%
|
$618,862
$37.97 P/Share
|
|
Jan 17
2024
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,726
+8.22%
|
$50,178
$3.02 P/Share
|
|
Jan 12
2024
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
2,200
-6.65%
|
$83,600
$38.09 P/Share
|